Development of pneumococcal mastoiditis due to multidrug-resistant serotype 19A despite three doses of 13-valent pneumococcal vaccine
| Autor: | Richard C. Ruck, Matthew D. Eberly |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Serotype
Mastoiditis Time Factors Fever Microbial Sensitivity Tests medicine.disease_cause Risk Assessment Severity of Illness Index Pneumococcal Infections Pneumococcal conjugate vaccine Microbiology Pneumococcal Vaccines Drug Resistance Multiple Bacterial Streptococcus pneumoniae otorhinolaryngologic diseases medicine Humans Serotyping Vaccines Conjugate business.industry Infant General Medicine medicine.disease Combined Modality Therapy Middle Ear Ventilation Anti-Bacterial Agents Vaccination Multiple drug resistance Treatment Outcome Otorhinolaryngology Pneumococcal vaccine Acute Disease Pediatrics Perinatology and Child Health Female business Complication Follow-Up Studies medicine.drug |
| Zdroj: | International Journal of Pediatric Otorhinolaryngology. 76:1849-1851 |
| ISSN: | 0165-5876 |
| Popis: | Acute mastoiditis is a potential complication of acute otitis media (AOM), with Streptococcus pneumoniae historically the most common pathogen isolated. Following the release of the 7-valent pneumococcal conjugate vaccine in 2000, a marked decline in invasive pneumococcal disease and a smaller reduction in pneumococcal AOM were observed, but data regarding its impact on acute mastoiditis are limited. With the recent introduction of the 13-valent pneumococcal conjugate vaccine (PCV13), it is anticipated that pneumococcal AOM and invasive disease will further diminish. We report a case of acute mastoiditis from a multidrug-resistant serotype 19A S. pneumoniae in an immunocompetent child who had received three PCV13 vaccinations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect